GLP-1 (glucagon-like peptide) medications, such as Ozempic and Wegovy, have seen a surge in popularity over the past few ...
Axios Vitals on MSN29d
Insurers push back on Medicare and Medicaid coverage for GLP-1sMedicare currently only covers GLP-1s for diabetes and heart disease ... The intrigue: Employers and insurers are often on ...
Between 2023 and 2024, employer coverage of GLP-1s increased by 8%. Although some employers cover GLP-1 medications only for diabetes treatment, a growing number are reconsidering this policy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback